Literature DB >> 25028913

Do ask, do tell: clinicians and the U.S. National AIDS strategy.

Kenneth H Mayer1.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 25028913     DOI： 10.1097/QAD.0000000000000274

Source DB:  PubMed          Journal:  AIDS        ISSN： 0269-9370            Impact factor:   4.177


× No keyword cloud information.
  5 in total

1.  A Qualitative Study of Medical Mistrust, Perceived Discrimination, and Risk Behavior Disclosure to Clinicians by U.S. Male Sex Workers and Other Men Who Have Sex with Men: Implications for Biomedical HIV Prevention.

Authors:  Kristen Underhill; Kathleen M Morrow; Christopher Colleran; Richard Holcomb; Sarah K Calabrese; Don Operario; Omar Galárraga; Kenneth H Mayer
Journal:  J Urban Health       Date:  2015-08       Impact factor: 3.671

2.  How well are U.S. primary care providers assessing whether their male patients have male sex partners?

Authors:  Pollyanna R G Chávez; Laura G Wesolowski; Philip J Peters; Christopher H Johnson; Muazzam Nasrullah; Emeka Oraka; Euna M August; Elizabeth DiNenno
Journal:  Prev Med       Date:  2017-11-07       Impact factor: 4.018

3.  Early Adopters: Correlates of HIV Chemoprophylaxis Use in Recent Online Samples of US Men Who Have Sex with Men.

Authors:  Kenneth H Mayer; Catherine E Oldenburg; David S Novak; Steven A Elsesser; Douglas S Krakower; Matthew J Mimiaga
Journal:  AIDS Behav       Date:  2016-07

4.  Seasons of Risk: Anticipated Behavior on Vacation and Interest in Episodic Antiretroviral Pre-exposure Prophylaxis (PrEP) Among a Large National Sample of U.S. Men Who have Sex with Men (MSM).

Authors:  Steven A Elsesser; Catherine E Oldenburg; Katie B Biello; Matthew J Mimiaga; Steven A Safren; James E Egan; David S Novak; Douglas S Krakower; Ron Stall; Kenneth H Mayer
Journal:  AIDS Behav       Date:  2016-07

5.  Give PrEP a chance: moving on from the "risk compensation" concept.

Authors:  Daniela Rojas Castro; Rosemary M Delabre; Jean-Michel Molina
Journal:  J Int AIDS Soc       Date:  2019-08       Impact factor: 5.396
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.